Sandu Pharma Q1 results, AGM on Sep 11, new auditor proposed

Related Party TransactionsResults View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

-5.7%1-day move

₹39.25

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————-5.7-3.3-4.4-3.2-3.2-3.2-3.1-5.8——

Up moveDown movePending

AI summary

Sandu Pharma approved Q1 FY27 results: revenue Rs 1,638.88 lakhs (vs Rs 1,669.90 YoY), PBT Rs 36.05 lakhs (vs Rs 33.87). 41st AGM set for September 11, 2026 via video conferencing. Record date for FY26 dividend is September 4, with book closure Sep 4 to 11. Board proposed appointing M/s. Dave & Dave as statutory auditors for 5 years from FY27, replacing Dileep & Prithvi whose term ended. Members approval sought for material related party transactions with Sandu Brothers Pvt Ltd.

Likely market impact

Routine Q1 results with flat revenue and slight PBT growth. AGM and dividend record date set. New auditor proposed for 5-year term after previous auditor completed term.